Author
@Asktraders1 Asktraders1
High-volume UK/US pre-market news and analyst-roundup aggregator, no original analysis
Publishes a steady stream of pre-market mover lists, sell-si
trader score
·
hit rate
·
mean α
·
signals 14d
90
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Not yet in the scored-bets universe (fewer than 20 scoreable calls). Their last-14d mentions, direction-adjusted, have moved -0.7% since posting (mean over 18 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-08-28 | · | @Asktraders1 | · | Forgent will increase its Peak Hill stake to 99% before an 8,700-meter drilling campaign. | · | tweet ↗ |
| 2026-08-28 | · | @Asktraders1 | · | Reports Forgent's share count reached 44.4 billion after a £0.8M placing, further diluting holders. | · | tweet ↗ |
| 2026-08-28 | FORG | @Asktraders1 | -0.60 | Forgent hit a fresh low after interim results and a dilutive £0.8M placing. | · | tweet ↗ |
| 2026-08-28 | · | @Asktraders1 | · | Reports net liabilities fell from €7.03M to €3.13M after debt conversion and an equity placing. | · | tweet ↗ |
| 2026-08-28 | GILD | @Asktraders1 | +0.25 | Gilead now has a new single-tablet HIV treatment based on Biktarvy and lenacapavir. | — | tweet ↗ |
| 2026-08-28 | GILD | @Asktraders1 | +0.50 | Gilead won FDA approval for the once-daily Bixlenvo HIV regimen. | — | tweet ↗ |
| 2026-08-28 | GILD | @Asktraders1 | +0.35 | Reports Gilead's Q2 HIV sales reached $5.7B, up 12%, alongside Bixlenvo's US approval. | — | tweet ↗ |
| 2026-08-28 | GILD | @Asktraders1 | +0.35 | Phase 3 data showed efficacy comparable to Biktarvy; Q2 Biktarvy revenue was $3.8B, up 7%. | — | tweet ↗ |
| 2026-08-28 | GDWN.L | @Asktraders1 | +0.25 | Goodwin plans to return some sale proceeds to shareholders and target zero net debt. | · | tweet ↗ |
| 2026-08-28 | · | @Asktraders1 | · | Goodwin confirmed Rothschild is running a sale process for a major division generating £211M revenue. | · | tweet ↗ |
| 2026-08-28 | · | @Asktraders1 | · | Reports trading profit rose 118%, revenue 27% and the dividend 18%, but the ticker is only in thread context. | · | tweet ↗ |
| 2026-08-28 | GDWN | @Asktraders1 | +0.55 | Goodwin shares jumped over 10% after record annual results and confirmation of a divisional sale. | · | tweet ↗ |
| 2026-08-27 | ZM | @Asktraders1 | +0.20 | Reports Zoom rebounding 3.03% to $96.67. | -1.8% | tweet ↗ |
| 2026-08-27 | ZM | @Asktraders1 | -0.30 | Reports below-consensus Q3 EPS guidance despite higher full-year guidance. | -1.8% | tweet ↗ |
| 2026-08-27 | ZM | @Asktraders1 | -0.50 | Reports Zoom falling 7% after Q3 profit guidance missed consensus despite a Q2 beat. | -1.8% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.